KU Leuven to lead development of dual vaccine against yellow fever and rabies

(KU Leuven) Rabies and yellow fever claim ten thousands of lives each year. Vaccines already exist but various drawbacks that hinder their efficient distribution. One of them is the need to transport and store these vaccines at cool temperatures. The RABYD-VAX consortium, led by KU Leuven (University of Leuven, Belgium), has now started developing a cheap, temperature-stable, and easy-to-produce vaccine against both diseases at once.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news